Skip Main Navigation
Page Content
This event has ended

Save This Event

Event Saved

Xconomy's EXOME Presents: What's Hot in Boston Biotech


Thursday, May 11, 2017 at 1:30 PM (EDT)

Xconomy's EXOME Presents: What's Hot in Boston Biotech

Ticket Information

Ticket Type Sales End Price Fee Quantity
Regular Registration Ended $375.00 $7.95
Startup Special
For employees of startups less than 3 years old with 20 or fewer employees.
Ended $195.00 $4.89
Student Registration Ended $50.00 $1.99
At the Door Ended $425.00 $7.95

Share Xconomy's EXOME Presents: What's Hot in Boston Biotech

Event Details

Join us May 11 for Xconomy Forum: What's Hot in Boston Biotech!

After a 2016 filled with extreme highs and lows, biotech is in for yet another bumpy ride in 2017. Obamacare's future is uncertain. The 21st Century Cures Act is in place. Changes loom at the FDA, drug pricing remains a flashpoint, and the IPO market continues to sputter. Yet through it all, critical biotech advances are being made. In cancer immunotherapy, drug cocktails may boost the power of existing treatments. For the first time, a CRISPR-Cas9 gene editing product could be tested in a human being--and a gene therapy submitted for approval in the U.S. Patients and their advocates are being incorporated into the drug development and approval process like never before.

What ideas are Boston’s innovators focusing on? What are the most promising startups and big company programs, and how does their leadership plan to move ideas forward amidst the shifting political and healthcare landscape?

Join Xconomy as we bring together a group of Boston biotech’s top entrepreneurs, investors, and leaders to explore these and other topics on the life sciences horizon.

Confirmed speakers include:

  • Noubar Afeyan, Founder, Senior Managing Partner & CEO, Flagship Pioneering
  • Katrine Bosley, CEO, Editas Medicine
  • Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute
  • Stelios Papadopoulos, Chairman of the Board, Biogen; Co-founder & Chairman of the Board, Exelixis
  • Richard Pops, Chairman & CEO, Alkermes
  • Susan Windham-Bannister, Ph.D., President and CEO, Biomedical Growth Strategies; Managing Partner, Biomedical Innovation Advisors
  • Michael Gilman, CEO & Chairman, Arrakis Therapeutics
  • Abbie Celniker, Partner, Third Rock Ventures
  • David Schenkein, CEO, Agios Pharmaceuticals
  • Ed Kaye, President, CEO & Chief Medical Office, Sarepta Therapeutics
  • Tony Coles, Chairman & CEO, Yumanity Therapeutics
  • Jeremy Levin, CEO, Ovid Therapeutics; former CEO, Teva Pharmaceutical Industries
  • Peter Saltonstall, President & CEO, National Organization for Rare Disorders
  • Peter Koutoujian, Sheriff of Middlesex County, former member, Massachusetts House of Representatives
  • Teresa Lavoie, Partner, Fish & Richardson 
  • Paul McKenzie, EVP for Pharmaceutical Operations and Technology, Biogen



Registration & Networking: 12:30 - 1:30 pm 
Program: 1:30 - 5:30 pm
Networking Reception: 5:30 - 6:30 pm
Full agenda

Ticket Information
Tickets are transferable but not refundable.
To inquire about press registration, email

*Speakers and program schedule are subject to change.




Fish & Richardson





Shire           WUXI


Northeastern University

The Richmond Group

Alexandria Real Estate Equities


BioCrossroads • GE
Latham & Watkins • TEVA Pharmaceuticals
Texas Medical Center • UT Health Science Center

ARCH Venture Partners • Avalon Ventures
Flagship Pioneering • LaunchCapital • North Bridge Venture Partners
RA Capital • 
Santé Ventures • SR One • Third Rock Ventures

Acorda Therapeutics • Arrowhead Pharmaceuticals • Bayer
Foundation Medicine • Genocea Biosciences • Health Advances
Shire • Synlogic Therapeutics

Boston New Technology • Massachusetts Life Sciences Center

Have questions about Xconomy's EXOME Presents: What's Hot in Boston Biotech? Contact Xconomy

When & Where

Biogen- Building 9
300 Binney Street
Cambridge, MA 02142

Thursday, May 11, 2017 at 1:30 PM (EDT)

  Add to my calendar



Xconomy is a news and events organization focused on the innovation hubs of Boston, Boulder/Denver, Detroit/Ann Arbor, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at

Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.